Tbdev.Net maintains a narrowly scoped vulnerability footprint centered on the DR product, with disclosures reflecting miscellaneous or unclassified weakness patterns. Current severity, exploitation activity, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Tbdev.Net over time
Signals from CVEs in this vendor scope (2 CVEs).
2 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
Cross-site scripting (XSS) vulnerability in takeprofedit.php in TBDev.NET DR 11-10-05-BETA-SF1:111005 and earlier allows remote attackers to inject arbitrary web script or HTML via | Jul 17, 2007 | 2.6 | 18 | NO | YES |
CVE-2007-3839MEDIUM Cross-site scripting (XSS) vulnerability in takeprofedit.php in TBDev.NET DR 010306 and earlier allows remote attackers to inject arbitrary web script or HTML via a javascript: URI | Jul 17, 2007 | 4.0 | 14 | NO | NO |
Signals from CVEs in this vendor scope (2 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Tbdev.Net.
Media articles that mention a CVE ID that affects a product developed by Tbdev.Net — matched by CVE ID, not by vendor name.